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Abstract 
Background: Cataract is a major cause of childhood blindness worldwide. The purpose of this study was to deter-
mine the genetic cause of paediatric cataract in a South Australian family with a bilateral lamellar paediatric cataract 
displaying variable phenotypes.
Case presentation: Fifty-one genes implicated in congenital cataract in human or mouse were sequenced in an 
affected individual from an Australian (Caucasian) family using a custom Ampliseq library on the Ion Torrent Personal 
Genome Machine. Reads were mapped against the human genome (hg19) and variants called with the Torrent Suite 
software. Variants were annotated to dbSNP 137 using Ion Reporter (IR 1.6.2) and were prioritised for validation if they 
were novel or rare and were predicted to be protein changing. We identified a previously reported oligomerization 
disrupting mutation, c.62G > A (p.R21Q), in the Crystallin alpha A (CRYAA) gene segregating in this three generation 
family. No other novel or rare coding mutations were detected in the known cataract genes sequenced. Microsatellite 
markers were used to compare the haplotypes between the family reported here and a previously published family 
with the same segregating mutation. Haplotype analysis indicated a potential common ancestry between the two 
South Australian families with this mutation. The work strengthens the genotype-phenotype correlations between 
this functional mutation in the crystallin alpha A (CRYAA) gene and paediatric cataract.
Conclusion: The p.R21Q mutation is the most likely cause of paediatric cataract in this family. The recurrence of this 
mutation in paediatric cataract families is likely due to a familial relationship.
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Background
Congenital or paediatric cataract is one of the major 
causes of lifelong visual loss in children [1] and 8–25 % 
of congenital cataract are inherited [2]. Inherited cata-
racts can be transmitted as autosomal recessive, auto-
somal dominant or X-linked traits, although autosomal 
dominant is the most common mode of inheritance. Both 
genetic and clinical heterogeneity have been observed 
and congenital cataract can occur in isolation or be asso-
ciated with other systemic features as part of a metabolic 
or genetic syndrome [3].
Isolated inherited congenital cataracts have thus far 
been found to be associated with mutations in genes that 
encode structural proteins (including the crystallins), 
membrane proteins, transcription factors, signalling mol-
ecules and enzymes [4]. Crystallin genes are the largest 
known gene family linked with congenital cataract; muta-
tions in several members of this gene family are known 
to cause the disease. More than 60 different mutations 
in crystallin genes have been reported to date in patients 
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with paediatric cataracts and these mutations are associ-
ated with a range of cataract phenotypes [5, 6].
Here we aimed to determine the genetic cause of pae-
diatric cataract in a multi-generation South Australian 
family using a high throughput screen of known cata-
ract genes. We report a second occurrence of the p.R21Q 
mutation in the CRYAA gene and investigated the ances-
tral origins of the mutation between the two families with 
paediatric cataract.
Case presentation
Six members of the three generation Australian (Cauca-
sian) family CSA110 (Fig.  1) were diagnosed with pedi-
atric cataract. The proband CSA110.01 presented with 
bilateral lamellar cataracts diagnosed at 7  years of age 
and had bilateral cataract surgery at age 16. Her mother, 
CSA110.03 also had bilateral cataracts which were diag-
nosed at 12  years of age and had bilateral cataract sur-
gery at the age of 46. CSA110.07, the proband’s maternal 
uncle, had severe bilateral cataracts which were surgi-
cally removed at age 4 years. The proband’s grandmother, 
CSA110.04 had bilateral cataract surgery at the age of 76 
but no information was available on the cataract pheno-
type. Her brother, CSA110.05, had bilateral mild lamellar 
cataracts, with anterior cortical spokes (Fig.  2) and had 
cataract surgery at age 61. These siblings had surgery sig-
nificantly later than their children and grandchildren; the 
cataract of CSA110.05 was described as lamellar affecting 
the fetal nucleus indicating its congenital nature despite 
the late surgical intervention. The proband’s brother, 
CSA110.02 shows no evidence of cataracts at the last 
examination in 2005 when he was 20 years old.
Discussion
Due to the heterogeneity of congenital cataract, an 
approach was taken that allows screening of multiple 
genes simultaneously. DNA (Deoxyribonucleic acid) was 
extracted from whole blood from all participants using 
Fig. 1 Pedigree of family CSA110 with mutation in CRYAA. Individuals with ID numbers were examined by an ophthalmologist. Solid circles indicate 
affected females and solid squares indicate affected males. Plus sign indicates mutant allele and minus sign indicates wild type allele. Diagonal lines 
indicate the individual is deceased
Page 3 of 8Javadiyan et al. BMC Res Notes  (2016) 9:83 
the QIAamp DNA blood maxi kit (Qiagen, Hilden, Ger-
many) according to the manufacturer’s protocol. Fifty-
one genes known to cause congenital cataract in human 
or mouse were selected through a review of the literature 
and are listed in Additional file 1 [4, 7–18]. We included 
all the genes listed in a recent review of congenital cata-
ract genes [4] except gjf1 which does not appear to have 
a human analogue. Additional genes from more recent 
publications or not included in the aforementioned 
review were also included (Additional file 1).
PCR (polymerase chain reaction) primers to amplify 
coding and untranslated regions of the 51 genes were 
designed with the Ion Ampliseq Designer (Life Tech-
nologies, www.ampliseq.com). A total of 1216 ampli-
cons ranging from 125 bp to 225 bp covered 94.26 % of 
the target sequence. Primers were supplied in two pools, 
100  nM concentration each (Life Technologies, Carls-
bad, CA, USA). The sequencing library was prepared 
with the Ion AmpliSeq library kit version 2.0 according 
to the manufacturer’s protocols for affected individual 
CSA110.03. The amplified library was diluted to 10  pM 
and 25 μL was used for template preparation according to 
Ion PGM Template OT2 200 Kit protocol using Ion PGM 
Template OT2 200 Kit. The clonally amplified library 
then was enriched on Ion OneTouch ES.
Sequencing was performed on an Ion Torrent Personal 
Genome Machine using The Ion PGM Sequencing 200 
Kit v2 and an Ion 318 chip. Using Torrent Suite (version 
3.6.) and related plugins for coverage analysis and variant 
calling, 1197237 reads were mapped against the reference 
genome (hg19), of which 93.30 % were on target. An aver-
age read depth of 918.6 was calculated for total of 1216 
amplicons and 94.3 % of the target bases were covered at 
least 100×. Variant call format (VCF) files were uploaded 
to Ion Reporter V4.0 (https://ionreporter.lifetechnolo-
gies.com/ir/) for variant annotation. Variants were prior-
itized for further analysis if they were predicted to alter 
protein sequence, and were absent in dbSNP137, Exome 
Variant Server (EVS) (http://evs.gs.washington.edu/
EVS/) and in an in-house list of sequencing errors previ-
ously seen on this gene panel. The variant is present in 
Exome Aggregation Consortium (ExAC) with a minor 
allele frequency of 0.000016.
A total of 121 variants were annotated against 
dbSNP137, of which 1 was predicted to alter pro-
tein sequence. Interestingly, the detected muta-
tion (c.62G  >  A, p.R21Q) in CRYAA (NM_0003941, 
MIM#123580) was previously shown to be a oligomeri-
zation disrupting mutation in another South Austral-
ian family independently recruited to our congenital 
cataract research program (Family CSA91) [19]. All the 
affected family members as well as one unaffected mem-
ber (CSA110.02) carried the mutation as determined by 
Sanger sequencing (Fig.  3) using primers and methods 
described previously [19].
Haplotype analysis was performed in the family pre-
viously reported to carry the same missense muta-
tion (CSA91) [19] and the new family reported here 
Fig. 2 Phenotype of cataract in CSA110.05 showing lamellar and cortical cataract with white spokes
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(CSA110) to determine if the mutation has arisen in both 
families independently, or if they are distantly related. 
Three microsatellite markers (D21S1260, D21S1890 and 
D21S1912) on the q arm of chromosome 21 flanking the 
CRYAA gene were typed in all available members of the 
two families. Primer sequences for amplification of each 
marker are provided in Additional file 2. Forward prim-
ers were labelled on the 5′ end with fluorescent dye FAM 
or HEX. PCR reactions of 20  μl final volume consisting 
of 1× Coraload PCR buffer (Qiagen) which gave a final 
concentration of 1.5 mM Mg2+, 0.1 mM dNTPs (Roche 
Diagnostics), 0.5 μM each primer, 0.5 U Hot Star Plus Taq 
Polymerase (Qiagen) and 80 ng of DNA (5× Q solution) 
(Qiagen) was included at a final concentration of 1× for 
markers D21S1890 and D21S1912. PCR was performed 
on a Palm cycler (Corbett Life science, QIAGEN) with 1 
cycle of 95 °C for 5 min, followed by 35 cycles of 95 °C for 
30 s, 57  °C for 30 s, 72  °C for 30 s and a final extension 
step of 72 °C for 15 min. PCR products were each diluted 
1:15. Fragment analysis was carried out on a 3130xl 
Genetic Analyser (Life Technologies, NY USA) using 
GS500LIZ_3130 size standard at the Flinders Sequencing 
Facility (Flinders Medical Centre, Adelaide, South Aus-
tralia). Fragment sizes were determined by comparing to 
the size standard using Peak Scanner Software Version 
1 (Life Technologies). Haplotypes were reconstructed 
using Merlin [20]. A recombination event was detected in 
CSA91.05 between CRYAA and D21S2160.
All of the mutation carriers in family CSA110 share a 
haplotype across this region of chromosome 21 with the 
affected family members of CSA91, indicating that the 
mutation has likely arisen only once on this genetic back-
ground (Fig. 4). The haplotype carrying the mutant allele 
was identical in the two families, suggesting that the 
recurrence of the mutation was possibly due to a previ-
ously unrecognised familial relationship (Fig. 4a, b).
Conclusion
∝A-crystallin is expressed preferentially in the lens and 
is detectable during the early stages of lens development. 
It is present in high concentrations and is responsible for 
maintaining the transparency of the lens through chap-
erone like activities and by interacting with damaged or 
incorrectly folded proteins to prevent their precipitation 
[21]. It is expressed in the lens epithelium at low levels, 
and in the elongation zone at higher levels [22], and plays 
a role in the differentiation of lens epithelial cells to lens 
fibre cells.
Performing high throughput sequencing of 51 congeni-
tal cataract causing genes identified only one potential 
Fig. 3 Sequence chromatogram of all examined individuals at the c.62G > A mutation. All affected family members are heterozygous, as is an unaf-
fected individual CSA110.02
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disease causing mutation in family CSA110. This muta-
tion is located in CRYAA and segregated with the phe-
notype in the family. Of seven available family members, 
all five affected members carried the mutation, whilst 
one of the unaffected members also carried the muta-
tion indicating probable reduced penetrance. Previously, 
the same oligomerization disrupting mutation in CRYAA, 
c.62G > A (p.R21Q), was reported in an apparently unre-
lated Australian family with lamellar congenital cata-
ract of variable severity [19]. The detection of the same 
mutation in CRYAA in two families from the same state 
of Australia and with such a similar phenotype led us to 
question whether these families were related. Genetic 
analysis suggests that the mutation has arisen only once 
on the same haplotype, and therefore these families are 
likely to be distantly related. No genealogical link was 
readily identified on specific questioning. The muta-
tion was not detected previously in Australian controls, 
nor was it present in commonly accessed databases at 
the time of sequencing, however, it has subsequently 
been reported in the ExAC database (http://exac.broad-
institute.org/) with a minor allele frequency of 0.000016 
(i.e. 1.6/100,000 chromosomes). Thus, this variant is 
extremely rare, which is consistent with a role in a rare 
disease such as pediatric cataract.
Limitations of this study (and any amplicon based next 
generation sequencing platform) include missing cover-
age of target genes due to both limitations in oligo design 
and poor amplification of some amplicons. However, 
the CRYAA mutation is the most probable cause of the 
observed phenotype in this family as demonstrated by 
segregation in two families, and its reported functional 
effects [19]. Despite the proven advantages of exome 
sequencing platforms for genetic diagnosis in Mendelian 
and complex diseases, including congenital cataract [23–
25], we decided to use a targeted sequencing approach 
due to its lower cost (at the time of conducting current 
research) and the simplified analytical pipeline for tar-
geted re-sequencing. The findings from this study would 
be equally applicable to performing subset analysis of 
exome or genome sequencing data.
The phenotype in the previously reported family 
CSA91 is described as lamellar with variable severity [19] 
which is similar to the observed phenotype in CSA110 
with variability in both severity and age at diagnosis. The 
inheritance pattern in CSA110 is autosomal dominant, 
but the mutation is not fully penetrant, in agreement with 
the earlier report of this mutation [13]. Since the p.R21Q 
CRYAA mutation displays both intra- and inter-familial 
variability, we postulate the presence of modifier genes 
Fig. 4 Haplotype analysis in two families with congenital cataract and the same mutation in Crystallin alpha A (CRYAA) a: CSA110 (reported in this 
study) and b: CSA91 (previously reported family). Solid circles indicate affected females and solid squares indicate affected males. Only individu-
als with IDs were available for study. Marker and gene order is D21S1260, CRYAA, D21S1890 and D21S1912 (marker names are indicated on each 
pedigree). Alleles at each marker are presented as the size of the PCR product detected. Plus sign indicates Crystallin alpha A (CRYAA) mutation 
carrier. The segregating haplotype is boxed and is the same in both families. A recombination event between D21S1260 and CRYAA was observed in 
CSA91.05
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altering the penetrance of the mutation and the severity 
of the cataract. There have been previous suggestions of 
modifier genes involved in the development of congenital 
cataract [26–28], although such genes have not yet been 
identified. Of note, mutations in GJA3 and CRYBB2 have 
been reported with reduced penetrance in congenital and 
pediatric cataract in humans and a digenic cause of cata-
ract has been reported in a mouse model [28].
A phenotype of lamellar cataract with variable sever-
ity is starting to emerge in the literature for CRYAA 
mutations. To date, 11 mutations in CRYAA have been 
detected in congenital cataract patients with a variety of 
cataract phenotypes including lamellar cataract (Table 1). 
For example, Zhang et al., 2009, described a three-gener-
ation Chinese family with autosomal dominant cataract 
with a mutation in CRYAA (p.R12C). The proband was 
diagnosed with bilateral lamellar cataract at 1 year of age 
while his father has milder lamellar cataract diagnosed at 
45  years of age. Other family members were diagnosed 
with older ages of onset of cataracts. The phenotype in 
this Chinese family is similar in both appearance and 
severity to our two Australian families.
There have been several CRYAA mutations reported in 
multiple families, although the ancestral origins have not 
been assessed for most. Hansen et  al. [29], investigated 
the founder effect of a recurrent mutation (c.61C  >  T, 
p.R21 W) in 3 families using the SNP rs872331 located 55 
nucleotides upstream of the mutant codon. They detected 
an identical haplotype c. [6T; 61C] in two of the families 
which confirmed their common ancestral founder with 
subsequent genealogical studies. The detection of the c. 
[6C; 61C] haplotype in the third family suggested that the 
mutation arose independently in that family.
The observed mutation in family CSA110 and CSA91 
alters a highly conserved arginine residue at position 
21 to glutamine (Fig.  5). It lies within the N terminal 
domain of CRYAA which has been demonstrated to be 
important for subunit exchange and oligomerization. It 
has been suggested that the deletion of this highly con-
served amino acid which is located in a conserved motif 
(SRLFDQFFG), leads to disruption of the correct assem-
bly of quaternary alpha-crystallin structure [30]. West-
ern blotting of lens protein from a mutation carrier also 
showed a decrease in the ability of the protein to form 
higher order oligomers essential for its function [19]. 
There have been multiple reports of mutations alter-
ing the highly conserved arginine residue at position 21 
(p.R21 W and p.R21L) associated with a variety of con-
genital cataract phenotypes, indicating its importance for 
proper CRYAA function.
In conclusion, we have identified a second instance of 
the p.R21Q mutation in the CRYAA gene in a family with 
congenital cataract and demonstrated the likelihood of 
these two families being distantly related. Both families 
showed similar phenotypes of lamellar cataracts with 
variable age of onset and severity, demonstrating intra- 
and inter-familial variability and incomplete penetrance 
associated with this mutation. This study highlights the 
local founder effects that may be seen within a commu-
nity and further strengthens the genotype-phenotype 
correlations reported for the CRYAA gene with congeni-
tal cataract.
Consent
The study adhered to the tenets of the Declaration of Hel-
sinki and was approved by the Southern Adelaide Clini-
cal Human Research Ethics Committee. The proband 
of family CSA110 (individual 110.01) was identified on 
presentation to the eye clinic at Flinders Medical Centre 
(FMC), Adelaide, South Australia. Written informed con-
sent was obtained from all of the family members and/
or their guardians for publication of this Case Report 
and any accompanying images. A copy of the written 
consent is available for review by the Editor-in-Chief of 
Table 1 Mutations in crystallin alpha A (CRYAA) gene associated with pediatric or congenital cataract
Exon DNA change Protein change Mode of inheritance Reported phenotypes References
1 c.34C > T p.R12C AD Congenital, nuclear, lamellar [25, 31–34]
1 c.61C > T p.R21 W AD Congenital, laminar nuclear, polar, anterior polar [24, 29, 31, 35]
1 c.62G > A p.R21Q AD Lamellar [19]
1 c.62G > T p.R21L Sporadic Central posterior [36]
1 c.145C > T p.R49C AD Central nuclear [29, 37]
1 c.160C > T p.R54C AR Total, nuclear [31, 38]
1 c.161G > C p.R54P AD Y-sutural [39]
1 c.161G > T p.R54L AD Nuclear [40]
2 c.292G > A p.G98R AD Lamellar, punctate, Y-suture [41, 42]
3 c.346C > T p.R116C AD Zonular central nuclear, nuclear [41, 43, 44]
3 c.347G > A p.R116H AD Variable, nuclear, punctate, total [35, 45–47]
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this journal. Where participants were minor (under the 
age of 18) or unable to personally provide consent, writ-
ten informed consent was obtained from the parent or 
legal guardian. A detailed family history was obtained, 
and additional affected and unaffected family members 
invited to participate.
Abbreviations
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